Notably, the increased tumor aggressiveness has been associated with increased expression or altered localization of other actin-binding proteins such as β-catenin [30], actinin-4 [40], cortactin [41] and fascin [42] at the invasive region of tumors. The gene discussed is FSCN1; the disease is neoplasm.